We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




High Blood Sugar During Pregnancy Increases Risk of Diabetes

By LabMedica International staff writers
Posted on 02 Oct 2018
Mothers with elevated blood glucose during pregnancy, even if not high enough to meet the traditional definition of gestational diabetes, were significantly more likely to have developed type 2 diabetes a decade after pregnancy than their counterparts without high blood glucose.

In a recent study of children born to mothers with elevated or normal glucose, there was no statistical significant difference between the two groups of children in terms of their combined overweight and obesity, which was the study’s primary outcome. More...
However, when obesity was measured alone, children of mothers with elevated blood glucose were significantly more likely to be obese.

An international team of scientists led by those at the Northwestern University Feinberg School of Medicine (Chicago, IL, USA) examined associations of gestational diabetes (GD) with maternal glucose metabolism and childhood adiposity 10 to 14 years’ postpartum. The follow-up study evaluated the long-term outcomes of 4,697 mothers and 4,832 children; study visits occurred between February 13, 2013, and December 13, 2016. Gestational diabetes was defined post hoc using criteria consisting of one or more of the following 75-g oral glucose tolerance test results (fasting plasma glucose ≥92 mg/dL; 1-hour plasma glucose level ≥180 mg/dL; 2-hour plasma glucose level ≥153 mg/dL).

The scientists reported that the criteria for GD were met by 14.3% (672/4,697) of mothers overall and by 14.1% (683/4,832) of mothers of participating children. Among mothers with GD, 52.2% (346/663) developed a disorder of glucose metabolism versus 20.1% (791/3,946) of mothers without GD (odds ratio [OR], 3.44; risk difference [RD], 25.7%). Among children of mothers with GD, 39.5% (269/681) were overweight or obese and 19.1% (130/681) were obese versus 28.6% (1,172/4,094) and 9.9% (405/4,094), respectively, for children of mothers without GD. Among women with elevated blood glucose during pregnancy, nearly 11% had type 2 diabetes at the follow-up study visit 10 to 14 years after childbirth and about 42% had prediabetes. Of their counterparts who did not have elevated blood glucose during pregnancy, about 2% had type 2 diabetes and about 18% had prediabetes.

The authors concluded that among women with GD identified by contemporary criteria compared with those without it, GD was significantly associated with a higher maternal risk for a disorder of glucose metabolism during long-term follow-up after pregnancy. Barbara Linder, MD, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, Bethesda, MD, USA), said, “The differences in mothers and their children due to the mother’s higher blood glucose are very concerning. Even accounting for the mother’s weight, glucose had an independent effect. Our findings add to the motivation to find ways to help women at high risk for gestational diabetes who are or plan to get pregnant to take steps to reduce their risk.” The study was published on September 11, 2018, in the Journal of the American Medical Association.

Related Links:
Northwestern University Feinberg School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.